Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read More
Schrodinger Inc
Jefferies says small caps are starting to outperform and these stocks are the best way to play it
As small-cap stocks take center stage, these names with high liquidity could be worth taking a look at, Jefferies says.
Read More
Artificial intelligence drug hunters are nearing a pivotal stage in their development
Over the next 12 to 18 months, AI-first drug developers will provide updates on early clinical work that will help
Read More